Skip to main content
Log in

Antipsychotische Frühintervention verbessert die Prognose

Diagnostik und Intervention bei ersten psychotischen Episoden

  • Zertifizierte Fortbildung Psychiatrie
  • Published:
InFo Neurologie + Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Gore FM et al. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet 2011;377:2093-102

  2. Kessler RC et al. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry 2007;20:359-64

  3. Bowman S et al. Youth mental ill health and secondary school completion in Australia: time to act. Early Interv Psychiatry 2017;11:277-89

  4. Rinaldi M et al. First episode psychosis and employment: a review. Int Rev Psychiatry 2010;22:148-62

  5. Levi L et al. Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort. Eur Neuropsychopharmacol 2020;32:131-5

  6. Boonstra N et al. Duration of untreated psychosis and negative symptoms - A systematic review and meta-analysis of individual patient data. Schizophr Res 2012;142:12-9

  7. Penttilä M et al. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2014;205:88-94

  8. Bendall S et al. The trauma of being psychotic: an analysis of posttraumatic stress disorder in response to acute psychosis. In: Trauma and Psychosis. Routledge 2007. S. 70-86

  9. McGorry PD et al. Posttraumatic stress disorder following recent-onset psychosis: An unrecognized postpsychotic syndrome. J Nerv Ment Dis 1991;179:253-8

  10. Shaw K et al. The phenomenology of traumatic reactions to psychotic illness. J Nerv Ment Dis 1997;185:434-41

  11. Birchwood M et al. Early intervention in psychosis: the critical-period hypothesis. Int Clin Psychopharmacol 1998;13:31-40

  12. Lieberman JA et al. Delayed detection of psychosis: causes, consequences, and effect on public health. Am J Psychiatry 2000;157:1727-30

  13. Bird V et al. Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review. Br J Psychiatry 2010;197:350-6

  14. Fioravanti M et al. Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence. BMC Psychiatry 2012;12:64

  15. www.awmf.org/leitlinien/detail/ll/038-009.html

  16. Starzer MSK et al. Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis. Am J Psychiatry 2018;175:343-50

  17. Johnson J et al. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry 1991;48:1075-81

  18. Ohayon MM et al. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 2002;159:1855-61

  19. Østergaard SD et al. The association between psychotic mania, psychotic depression and mixed affective episodes among 14,529 patients with bipolar disorder. J Affect Disord 2013;147:44-50

  20. Slotema C et al. Comorbid diagnosis of psychotic disorders in borderline personality disorder: Prevalence and influence on outcome. Front Psychiatry 2018;9:84

  21. Cavelti M et al. Exploratory comparison of auditory verbal hallucinations and other psychotic symptoms among youth with borderline personality disorder or schizophrenia spectrum disorder. Early Interv Psychiatry 2019;13:1252-62

  22. Braakman M et al. Validity of 'post-traumatic stress disorder with secondary psychotic features': a review of the evidence. Acta Psychiatr Scand 2009;119:15-24

  23. Rasmussen AR et al. Schizophrenia-spectrum psychopathology in obsessive-compulsive disorder: an empirical study. Eur Arch Psychiatry Clin Neurosci 2019;1-10

  24. DGKJP, DGPPN. Autismus-Spektrum-Störungen im Kindes-, Jugend-und Erwachsenenalter. S3-Leitlinie. 2016. Herz MI et al. A program for relapse prevention in schizophrenia: a controlled study. Arch Gen Psychiatry 2000;57:277-83

  25. Leucht S et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 2012;379:2063-71

  26. Addington J et al. Symptom outcome 1 year after admission to an early psychosis program. Can J Psychiatry 2003;48:204-7

  27. Lieberman JA et al. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 2003;28:995-1003

  28. Tohen M et al. Two-year syndromal and functional recovery in 219 Cases of first-episode major affective dsorder with psychotic features. Am J Psychiatry 2000;157:220-8

  29. Désaméricq G et al. Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis. Eur J Clin Pharmacol 2014;70:127-34

  30. Leucht S et al. Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. Am J Psychiatry 2017;174:927-42

  31. DGPPN, DGBS. S3-Leitlinie zur Diagnostik und Therapie Bipolarer Störungen. Langversion; 2012

  32. Australian Clinical Guidelines for Early Psychosis. 2nd edition update. Melbourne: Orygen, The National Centre of Excellence in Youth Mental Health; 2016

  33. Chanen AM et al. Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial. Early Interv Psychiatry 2019

  34. Kordon A et al. S3-Leitline Zwangsstörungen (AWMF-Registernummer 038/017). DGPPN 2013

  35. Schäfer I et al. S3-Leitlinie Posttraumatische Belastungsstörung. Springer 2019

  36. Morrison AP et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet 2014;383:1395-403

  37. Pharoah F et al. Family intervention for schizophrenia. Cochrane Database of Systematic Reviews 2003 [cited 2016 Jun 27]. http://doi.wiley.com/10.1002/14651858.CD000088

  38. Modini M et al. Supported employment for people with severe mental illness: systematic review and meta-analysis of the international evidence. Br J Psychiatry 2016;209:14-22

  39. Lauber C et al. 10 Supported Employment. Soz Psychiatr Handb Für Psychosoz Prax-Band 2. 2013

  40. Ramsay CE et al. Life and treatment goals of individuals hospitalized for first-episode nonaffective psychosis. Psychiatry Res 2011;189:344-8

  41. Barrett EA et al. Suicidality in first episode psychosis is associated with insight and negative beliefs about psychosis. Schizophr Res 2010;123:257-62

  42. Nordentoft M et al. OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis: one-year follow-up of a randomised controlled trial. Br J Psychiatry 2002;181:98-106

  43. Barnett JH et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psych 2007;190:515-20

  44. Addington J et al. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand 2007;115:304-9

  45. De Vos C et al. The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis. Psychiatry Res 2020;113424

  46. Larsen TK et al. Substance abuse in first-episode non-affective psychosis. Schizophr Res 2006;88:55-62

  47. Turkington A et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psych 2009;195:242-8

  48. Whitehorn D et al. Multiple dimensions of recovery in early psychosis. Int Rev Psychiatry 2002;14:273-83

  49. Doyle R et al. First-episode psychosis and disengagement from treatment: a systematic review. Psychiatr Serv 2014;65:603-11

  50. Alvarez-Jimenez M et al. Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies. Schizophr Res 2012;139:116-28

  51. Birchwood M et al. Early intervention in psychotic relapse. Clin Psychol Rev 2001;21:1211-26

  52. McGorry PD et al. Cultures for mental health care of young people: an Australian blueprint for reform. Lancet Psychiatry 2014;1:559-68

  53. Correll CU et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: A systematic review, meta-analysis, and meta-regression. JAMA Psychiatry 2018;75:555-65

  54. Aceituno D et al. Cost-Effectiveness of early intervention in psychosis: systematic review. Br J Psychiatry 2019;215:388-94

  55. Rosenheck R et al. Cost-effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE Early Treatment Program. Schizophr Bull 2016;42:896-906

  56. Burkhardt E et al. Was tun, bevor es losgeht? FRITZ - Das Frühinterventions- und Therapiezentrum in Berlin. Z Für Psychiatr Psychol Psychother 2017;65:105-12

  57. Lambert M et al. Early detection and integrated care for adolescents and young adults with psychotic disorders: the ACCESS III study. Acta Psychiatr Scand 2017;136:188-200

  58. Leopold K et al. Angebote zur Früherkennung von Psychosen und bipolaren Störungen in Deutschland: Bestandsaufnahme. Nervenarzt 2015;86:352-8

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Karolina Leopold or Andreas Bechdolf.

Ethics declarations

K. Leopold hat Vortragshononare und Reisesponsoring von Janssen-Cilag, Lundbeck, Otsuka und Recordati erhalten, außerdem Forschungszuwendungen von Otsuka und Janssen-Cilag.

A. Bechdolf hat Vortragshononare und Reisesponsoring von Janssen-Cilag, Lundbeck und Otsuka erhalten, außerdem erhielt er Forschungszuwendungen von Otsuka und Janssen-Cilag.

Bei E. Burkhardt bestehen keine möglichen Interessenkonflikte.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.

Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leopold, K., Burkhardt, E. & Bechdolf, A. Diagnostik und Intervention bei ersten psychotischen Episoden. InFo Neurologie 23, 34–41 (2021). https://doi.org/10.1007/s15005-021-1845-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-021-1845-4

Navigation